FDA
-
-
-
-
-
-
-
Crinetics presents CAH trial data for atumelnant at ENDO 2026
-
-
-
-
-
-
-
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
-
-
-
-
-
-
-
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
-
-
-
-
-
-
Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
-
-
-
-
-
-
-
Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome
-
-
-
-
-
-
-
Piper Sandler: 'We Remain Bullish on Crinetics (CRNX)'
-
328,334 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

